Payment overview · 2025
General Payments
$106.68
6 reported records · 5 companies
Healthcare provider profile · identity verified
James C Wright, DO
Allopathic & Osteopathic Physicians|Family Medicine · LAKE VILLAGE, AR · NPI 1053390781
Verified facts
What the public records show
CMS Open Payments records show James C Wright, DO received $106.68 in general payments during 2025 across 6 reported records.
Exact Sciences Corporation accounted for 27.3% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 6 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Jardiance, Ozempic.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 52 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 13 claims for Synthroid by this doctor in 2024.
Boehringer Ingelheim Pharmaceuticals, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 123636 records involving 49438 distinct recipient NPIs. Public Medicare Part D data also shows 114 claims for Jardiance by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 65 claims for Ozempic by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $29.10 | 27.3% | 2 | 2025 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $24.15 | 22.6% | 1 | 2025 |
| ABBVIE INC. | Unresolved — no canonical attribution shown | $19.85 | 18.6% | 1 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $19.84 | 18.6% | 1 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $13.74 | 12.9% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $106.68 | 6 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| JARDIANCE Normalized: jardiance |
Drug | Boehringer Ingelheim Pharmaceuticals, Inc. | $24.15 | 1 | 2025 |
Source payment records
|
|||||
| EMBLAVEO Normalized: emblaveo |
Drug | ABBVIE INC. | $19.85 | 1 | 2025 |
Source payment records
|
|||||
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $19.84 | 1 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $14.83 | 1 | 2025 |
Source payment records
|
|||||
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $14.27 | 1 | 2025 |
Source payment records
|
|||||
| EVENITY Normalized: evenity |
Biological | Amgen Inc. | $13.74 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| JARDIANCE jardiance |
2025 | Jardiance | 2024 | 114 | exact normalized | Medicare Part D |
| Ozempic ozempic |
2025 | Ozempic | 2024 | 65 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
52 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
13 | suppressed by CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 123636 supporting records · 49438 recipient NPIs · example record 1221811583 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
114 | 18 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
65 | 11 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 1113 | 132 |
| Atorvastatin Calcium | Atorvastatin Calcium | 690 | 121 |
| Alprazolam | Alprazolam | 625 | 83 |
| Amlodipine Besylate | Amlodipine Besylate | 589 | 101 |
| Omeprazole | Omeprazole | 506 | 78 |
| Gabapentin | Gabapentin | 433 | 70 |
| Meloxicam | Meloxicam | 357 | 56 |
| Pantoprazole Sodium | Pantoprazole Sodium | 325 | 58 |
| Metformin Hcl | Metformin Hcl | 295 | 51 |
| Furosemide | Furosemide | 291 | 58 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 266 | 50 |
| Losartan Potassium | Losartan Potassium | 246 | 44 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 246 | 33 |
| Hydrochlorothiazide | Hydrochlorothiazide | 244 | 44 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 244 | 42 |
| Simvastatin | Simvastatin | 234 | 45 |
| Oxycodone Hcl | Oxycodone Hcl | 230 | 30 |
| Potassium Chloride | Potassium Chloride | 214 | 43 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 199 | 31 |
| Escitalopram Oxalate | Escitalopram Oxalate | 195 | 32 |
| Metoprolol Tartrate | Metoprolol Tartrate | 195 | 33 |
| Metoprolol Succinate | Metoprolol Succinate | 186 | 44 |
| Tamsulosin Hcl | Tamsulosin Hcl | 186 | 34 |
| Levothyroxine Sodium | Levothyroxine Sodium | 179 | 33 |
| Lisinopril | Lisinopril | 172 | 33 |
| Duloxetine Hcl | Duloxetine Hcl | 165 | 22 |
| Allopurinol | Allopurinol | 135 | 25 |
| Jardiance | Empagliflozin | 114 | 18 |
| Tramadol Hcl | Tramadol Hcl | 114 | 28 |
| Clonidine Hcl | Clonidine Hcl | 110 | 20 |
| Zolpidem Tartrate | Zolpidem Tartrate | 107 | 17 |
| Clopidogrel | Clopidogrel Bisulfate | 103 | 24 |
| Tizanidine Hcl | Tizanidine Hcl | 103 | 17 |
| Trazodone Hcl | Trazodone Hcl | 101 | 22 |
| Spironolactone | Spironolactone | 100 | 18 |
| Diclofenac Sodium | Diclofenac Sodium | 98 | 17 |
| Eliquis | Apixaban | 97 | 15 |
| Clonazepam | Clonazepam | 96 | 12 |
| Lorazepam | Lorazepam | 91 | 14 |
| Pravastatin Sodium | Pravastatin Sodium | 90 | 17 |
| Glipizide | Glipizide | 88 | 15 |
| Azithromycin | Azithromycin | 87 | 58 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 87 | 16 |
| Pregabalin | Pregabalin | 81 | 14 |
| Temazepam | Temazepam | 80 | 16 |
| Ibuprofen | Ibuprofen | 79 | 23 |
| Sertraline Hcl | Sertraline Hcl | 77 | 13 |
| Amitriptyline Hcl | Amitriptyline Hcl | 76 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 75 | 17 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 74 | 11 |
| Mirtazapine | Mirtazapine | 70 | 11 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 70 | 11 |
| Ezetimibe | Ezetimibe | 69 | 14 |
| Nifedipine Er | Nifedipine | 66 | 14 |
| Carvedilol | Carvedilol | 65 | 15 |
| Chlorthalidone | Chlorthalidone | 65 | 12 |
| Ozempic | Semaglutide | 65 | 11 |
| Glipizide Er | Glipizide | 64 | 11 |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 61 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 61 | suppressed |
| Mounjaro | Tirzepatide | 61 | 13 |
| Fluticasone Propionate | Fluticasone Propionate | 60 | 26 |
| Famotidine | Famotidine | 59 | 11 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 57 | 25 |
| Enalapril Maleate | Enalapril Maleate | 55 | suppressed |
| Linzess | Linaclotide | 52 | suppressed |
| Celecoxib | Celecoxib | 51 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 50 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 49 | suppressed |
| Bumetanide | Bumetanide | 47 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 44 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 43 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 43 | 15 |
| Megestrol Acetate | Megestrol Acetate | 43 | 11 |
| Ondansetron Hcl | Ondansetron Hcl | 42 | 14 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 41 | suppressed |
| Baclofen | Baclofen | 39 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 39 | suppressed |
| Atenolol | Atenolol | 38 | suppressed |
| Latanoprost | Latanoprost | 38 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 37 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 37 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 36 | suppressed |
| Glimepiride | Glimepiride | 36 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 36 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 36 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 35 | suppressed |
| Amoxicillin | Amoxicillin | 35 | 24 |
| Diazepam | Diazepam | 35 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 35 | 11 |
| Fluconazole | Fluconazole | 34 | 18 |
| Ibu | Ibuprofen | 34 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 34 | 11 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 34 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 33 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 33 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 31 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 30 | suppressed |
| Naproxen | Naproxen | 30 | suppressed |
| Lactulose | Lactulose | 29 | suppressed |
| Levofloxacin | Levofloxacin | 29 | 23 |
| Memantine Hcl | Memantine Hcl | 29 | suppressed |
| Carisoprodol | Carisoprodol | 28 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 28 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 28 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 28 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 28 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 28 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 28 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 27 | suppressed |
| Aripiprazole | Aripiprazole | 27 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 27 | 24 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 27 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 26 | suppressed |
| Ondansetron Odt | Ondansetron | 26 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 26 | suppressed |
| Sucralfate | Sucralfate | 26 | suppressed |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 25 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 25 | suppressed |
| Prednisone | Prednisone | 25 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 25 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 24 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 24 | suppressed |
| Levemir Flexpen | Insulin Detemir | 24 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 24 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 24 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 23 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 23 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 23 | suppressed |
| Fentanyl | Fentanyl | 23 | suppressed |
| Levetiracetam | Levetiracetam | 23 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 22 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 22 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 22 | suppressed |
| Irbesartan | Irbesartan | 22 | suppressed |
| Methocarbamol | Methocarbamol | 22 | suppressed |
| Ramipril | Ramipril | 22 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 22 | suppressed |
| Methylprednisolone | Methylprednisolone | 21 | 20 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 21 | 16 |
| Symbicort | Budesonide/Formoterol Fumarate | 21 | suppressed |
| Anastrozole | Anastrozole | 20 | suppressed |
| Januvia | Sitagliptin Phosphate | 20 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 19 | 11 |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 19 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 18 | suppressed |
| Diclofenac Potassium | Diclofenac Potassium | 18 | suppressed |
| Indapamide | Indapamide | 18 | suppressed |
| Nabumetone | Nabumetone | 18 | suppressed |
| Nitroglycerin | Nitroglycerin | 18 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 18 | suppressed |
| Topiramate | Topiramate | 18 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 17 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 17 | suppressed |
| Estradiol | Estradiol | 17 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 17 | suppressed |
| Colchicine | Colchicine | 16 | suppressed |
| Letrozole | Letrozole | 16 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 16 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 15 | suppressed |
| Repatha Sureclick | Evolocumab | 15 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 14 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 13 | suppressed |
| Gemfibrozil | Gemfibrozil | 13 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 13 | suppressed |
| Synthroid | Levothyroxine Sodium | 13 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 12 | suppressed |
| Buprenorphine Hcl | Buprenorphine Hcl | 12 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 12 | suppressed |
| Entecavir | Entecavir | 12 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 12 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 12 | suppressed |
| Lamotrigine | Lamotrigine | 12 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 12 | suppressed |
| Ranolazine Er | Ranolazine | 12 | suppressed |
| Risperidone | Risperidone | 12 | suppressed |
| Rivastigmine | Rivastigmine | 12 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 12 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 12 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 12 | suppressed |
| Carbamazepine Er | Carbamazepine | 11 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 11 | 11 |
| Fenofibric Acid | Fenofibric Acid (Choline) | 11 | suppressed |
| Olanzapine | Olanzapine | 11 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 11 | suppressed |
| Sotalol | Sotalol Hcl | 11 | suppressed |
| Sulindac | Sulindac | 11 | suppressed |
| Verapamil Er | Verapamil Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $106.68 · 6 records | Exact Sciences Corporation | Cologuard Collection Kit, EMBLAVEO, EVENITY, JARDIANCE, Ozempic, The Cologuard Plus Collection Kit | 4 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Jardiance play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error